Formycon AG (0W4N.L) Financials

0W4N.L Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 739.5 million 340.4 million
June 30, 2025 742.6 million 334.2 million
Dec. 31, 2024 771.7 million 309.9 million
June 30, 2024 947.8 million 371.5 million

0W4N.L Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 4.0 million ?
June 30, 2025 6.6 million 683000
Dec. 31, 2024 7.1 million ?
June 30, 2024 -32.2 million 802000

0W4N.L Net Income

No data available :(

0W4N.L Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 68.8 million - 9.6 million
June 30, 2025 27.3 million - 10.2 million
Dec. 31, 2024 41.8 million 9.1 million 10.6 million
June 30, 2024 40.6 million 9.6 million 10.9 million

0W4N.L Shares Outstanding

No data available :(

0W4N.L Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 572000 4.5 million 10.8 million -
June 30, 2025 165000 8.2 million 9.5 million 738000
Dec. 31, 2024 563000 6.8 million 11.4 million 709000
June 30, 2024 982000 9.7 million 9.9 million 593000

0W4N.L Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 35.5 million 18.5 million
June 30, 2025 9.0 million 22.4 million
Dec. 31, 2024 42.8 million 29.9 million
June 30, 2024 26.9 million 25.0 million

0W4N.L

Price: €19.76

52 week price:
15.90
80.20

Earnings Per Share: -1.22 EUR

Exchange: LSE

Sector: Healthcare

Industry: Pharmaceuticals, Biotechnology & Life Sciences

Country: Germany

Market Capitalization: 150.0 million

Links: